This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraus, I.
Right arrow Articles by Skomedal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraus, I.
Right arrow Articles by Skomedal, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2006, p. 1310-1317, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1310-1317.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas

Irene Kraus,1,{dagger} Tor Molden,1,{dagger}* Ruth Holm,2 A. Kathrine Lie,2 Frank Karlsen,3 Gunnar B. Kristensen,4 and Hanne Skomedal3

Institute of Pathology, National University Hospital, 0027 Oslo, Norway,1 Department of Pathology, Norwegian Radium Hospital, 0310 Oslo, Norway,2 NorChip AS, 3490 Klokkarstua, Norway,3 Department of Gynaecologic Oncology, Norwegian Radium Hospital, 0310 Oslo, Norway4

Received 12 September 2005/ Returned for modification 12 December 2005/ Accepted 13 January 2006

The oncogenic potential of the human papillomavirus (HPV) early genes E6 and E7 is well established and a source of interest with regard to HPV testing for cervical carcinoma. Here we present a study performed with 204 histologically confirmed invasive cervical squamous cell carcinomas (SCCs) in which we evaluated the HPV E6 and E7 mRNA detection assay PreTect HPV-Proofer for detection of high-risk HPV types 16, 18, 31, 33, and 45. For further evaluation, detection of E6 and E7 mRNA from HPV types 35, 52, and 58 by real-time multiplex nucleic acid sequence-based amplification was also included. For comparison and to assess the overall prevalence of various HPV types, samples were also tested for HPV DNA by both consensus and type-specific PCR, reverse line blotting, sequencing, and in situ hybridization. The overall prevalence of HPV was 97%. HPV E6 and E7 transcripts were detected in 188 of 204 (92%) biopsy specimens, of which 181 contained one of the following HPV types: 16, 18, 31, 33, or 45. Consensus PCR and type-specific PCR detected HPV in 187 of 204 and 188 of 204 (92%) specimens, respectively. In conclusion, this study verifies the presence of HPV E6 and E7 mRNA in SCCs and demonstrates that HPV infections among Norwegian women with SCCs are limited mainly to the five high-risk types, 16, 18, 31, 33, and 45. This, together with the fact that PreTect HPV-Proofer detects the HPV oncogenic transcripts, suggests that the assay is a valuable approach in the field of HPV detection in cervical carcinoma.

* Corresponding author. Mailing address: Institute of Pathology, National University Hospital, Sognsveien 20, 0027 Oslo, Norway. Phone: 47 40403484. Fax: 47 32798801. E-mail: t.e.f.molden{at}medisin.uio.no.

{dagger} Irene Kraus and Tor Molden contributed equally to this work.

Journal of Clinical Microbiology, April 2006, p. 1310-1317, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1310-1317.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Trope, A., Sjoborg, K., Eskild, A., Cuschieri, K., Eriksen, T., Thoresen, S., Steinbakk, M., Laurak, V., Jonassen, C. M., Westerhagen, U., Jacobsen, M. B., Lie, A. K. (2009). Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia. J. Clin. Microbiol. 47: 2458-2464 [Abstract] [Full Text]  
  • Cattani, P., Siddu, A., D'Onghia, S., Marchetti, S., Santangelo, R., Vellone, V. G., Zannoni, G. F., Fadda, G. (2009). RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus. J. Clin. Microbiol. 47: 2136-2141 [Abstract] [Full Text]  
  • Cuschieri, K., Wentzensen, N. (2008). Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical Neoplasia. Cancer Epidemiol. Biomarkers Prev. 17: 2536-2545 [Abstract] [Full Text]  
  • Kraus, I., Driesch, C., Vinokurova, S., Hovig, E., Schneider, A., von Knebel Doeberitz, M., Durst, M. (2008). The Majority of Viral-Cellular Fusion Transcripts in Cervical Carcinomas Cotranscribe Cellular Sequences of Known or Predicted Genes. Cancer Res. 68: 2514-2522 [Abstract] [Full Text]  
  • Vinokurova, S., Wentzensen, N., Kraus, I., Klaes, R., Driesch, C., Melsheimer, P., Kisseljov, F., Durst, M., Schneider, A., von Knebel Doeberitz, M. (2008). Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions. Cancer Res. 68: 307-313 [Abstract] [Full Text]  
  • Castle, P. E., Dockter, J., Giachetti, C., Garcia, F. A.R., McCormick, M. K., Mitchell, A. L., Holladay, E. B., Kolk, D. P. (2007). A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer. Clin. Cancer Res. 13: 2599-2605 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»